Sandesh Seth

Sandesh Seth is a prominent figure in the pharmaceutical and investment banking industries with over 25 years of experience. He is currently the Chief Executive Officer and Chairman of the Board at Actinium Pharmaceuticals, Inc., a biotechnology firm.1 2

Professional Background

Investment Banking Experience:: Sandesh has held positions at several notable firms, including:

Laidlaw & Co (UK) Ltd.
Cowen & Co.

Equity Research:: He has worked in equity research at:

Bear Stearns
Commonwealth Associates

Pharmaceutical Industry:: Sandesh has experience with major pharmaceutical companies, including:

Pfizer
Warner-Lambert
SmithKline

In these roles, he focused on strategic planning, business development, and R&D project management.1

Education and Certifications

MBA in Finance from New York University
M.S. in Pharmaceutical Sciences from the University of Oklahoma Health Center
B.Sc. in Chemistry from Bombay University
Regulatory Affairs Certified by the Regulatory Affairs Professionals Society1

Entrepreneurial Ventures

Sandesh Seth is also known for his role as a Managing Partner at AmerAsia Capital Partners, LLC (formerly known as Amerasia Capital Group, LLC), a consulting firm.4 5 He has been involved in various healthcare-related ventures, including:

Co-founding and serving as chairman of Relmada Therapeutics Inc., a specialty pharma company focused on CNS therapeutics1 4
Heading Healthcare Investment Banking at Laidlaw & Company (UK) Ltd.3

Achievements and Expertise

Published several scientific articles
Awarded the University Regents Award for Research Excellence at the University of Oklahoma
Holds patents related to the use of radiopharmaceuticals as conditioning agents for adoptive cell therapies and therapeutic combinations1

Sandesh Seth's diverse experience in pharmaceuticals, investment banking, and entrepreneurship has positioned him as a respected figure in the biotechnology and healthcare industries.